SUPRAMOLECULAR CHEMISTRy
3
6H, CH3–19), 0.87 (d, J = 5.1 Hz, 6H, CH3–21), 0.61 (s, 6H,
CH3–18). 1H NMR (DMSO-d6): δ 8.18 (s, 2H, CH-triazole ring),
7.34–7.25 (m, 4H, Ar–H), 5.58 (s, 4H, Ph–CH2–triazole ring),
5.10 (s, 4H, O–CH2–triazole ring), 4.45 (d, J = 4.5 Hz, 2H,
3α–OH), 3.48–3.37 (m, 2H, 3β–H), 0.87 (s, 6H, CH3–19), 0.84
(d, J = 6.3 Hz, 6H, CH3–21), 0.57 (s, 6H, CH3–18). 13C NMR
(CDCl3): δ 174.11, 143.58, 135.58, 130.01, 128.33, 127.54,
123.69, 71.79, 57.38, 56.46, 55.88, 53.71, 42.69, 42.05,
40.39, 40.13, 36.42, 35.80, 35.29, 34.54, 31.06, 30.82, 30.52,
28.16, 27.16, 26.38, 24.16, 23.34, 20.78, 18.21, 11.99. 13C
NMR (DMSO-d6): δ 173.02, 172.94, 142.17, 136.48, 129.20,
127.78, 127.59, 124.80, 69.82, 56.91, 55.99, 55.43, 52.49,
42.22, 41.49, 39.93, 39.78, 39.63, 39.22, 38.94, 38.67, 36.26,
35.33, 35.12, 34.69, 34.17, 30.49, 30.41, 30.35, 27.64, 26.87,
26.12, 23.79, 23.24, 20.37, 18.01, 11.77. HRMS (MALDI)
(m/z): calcd for C62H92N6O6Cl [M + Cl]: 1051.6766; found:
1051.6735.
Compound (12). yield 58% (255 mg), m.p. 99–105 °C.
FT-IR (KBr) νmax: 3423, 2935, 2862, 1734, 1448, 1164, 754. 1H
NMR (CDCl3): δ 7.55 (s, 2H, CH-triazole ring), 7.27–7.22 (m, 4H,
Ar–H), 5.52 (s, 4H, Ph–CH2–triazole ring), 5.19 (s, 4H, O–CH2–
triazole ring), 3.95 (s, 2H, 12β–H), 3.66–3.55 (m, 2H, 3β–H),
0.91 (s, 6H, CH3–19), 0.92 (d, J = 8.1 Hz, 6H, CH3–21), 0.65 (s,
6H, CH3–18). 1H NMR (DMSO-d6): δ 8.18 (s, 2H, CH-triazole
ring), 7.43–7.40 (m, 4H, Ar–H), 5.58 (s, 4H, Ph–CH2–triazole
ring), 5.10 (s, 4H, O–CH2–triazole ring), 4.46 (d, J = 4.3 Hz, 2H,
3α–OH), 4.18 (d, J = 4.1 Hz, 2H, 12α–OH), 3.77 (d, J = 3.5 Hz,
2H, 12β–H), 3.41–3.28 (m, 2H, 3β–H), 0.88 (d, J = 6.3 Hz, 6H,
CH3–21), 0.84 (s, 6H, CH3–19), 0.55 (s, 6H, CH3–18). 13C NMR
(CDCl3): δ 174.07, 143.58, 135.59, 130.01, 128.37, 127.54,
123.69, 76.58, 73.03, 71.71, 57.41, 53.72, 48.24, 47.13, 46.45,
42.04, 36.39, 35.97, 35.22, 35.12, 34.08, 33.60, 31.09, 30.77,
30.45, 29.66, 28.65, 27.45, 27.09, 26.11, 23.62, 23.12, 17.23,
12.66. 13C NMR (DMSO-d6): δ 172.99, 142.20, 136.46, 129.21,
127.75, 127.60, 124.78, 70.94, 69.90, 56.90, 52.50, 47.40,
46.11, 45.95, 41.57, 39.78, 39.23, 38.95, 38.67, 36.26, 35.60,
35.11, 34.83, 33.77, 32.88, 30.55, 30.20, 28.54, 27.09, 26.95,
26.05, 23.44, 23.05, 16.80, 12.33. HRMS (MALDI) (m/z): calcd
for C62H92N6O8Cl [M + Cl]: 1083.6665; found: 1083.6647.
Compound (13). yield 40% (172 mg), m.p. 108–115 °C.
FT-IR (KBr) νmax: 3420, 2930, 1734, 1464, 1168, 753. 1H
NMR (CDCl3): δ 7.58 (s, 2H, CH-triazole ring), 7.27–7.20
(m, 4H, Ar–H), 5.52 (s, 4H, Ph–CH2–triazole ring), 5.19 (s,
4H, O–CH2–triazole ring), 3.93 (s, 2H, 12β–H), 3.83 (s, 2H,
7β–H), 3.51–3.20 (m, 2H, 3β–H), 0.92 (d, J = 5.7 Hz, 6H,
CH3–21), 0.87 (s, 6H, CH3–19), 0.64 (s, 6H, CH3–18). 1H NMR
(DMSO-d6): 8.18 (s, 2H, CH-triazole ring), 7.40–7.25 (m, 4H,
Ar–H), 5.58 (s, 4H, Ph–CH2–triazole ring), 5.10 (s, 4H, O–
CH2–triazole ring), 4.31 (d, J = 4.4 Hz, 2H, 3α–OH), 4.10 (d,
J = 3.5 Hz, 2H, 12α–OH), 4.00 (d, J = 3.4 Hz, 2H, 7α–OH), 3.75
(d, J = 3.17 Hz, 2H, 12β–H), 3.61 (s, 2H, 7β–H), 3.23–3.14
(m, 2H, 3β–H), 0.81 (s, 6H, CH3–19), 0.89 (d, J = 6.2 Hz, 6H,
CH3–21), 0.55 (s, 6H, CH3–18). 13C NMR (CDCl3): δ 174.22,
143.53, 135.60, 129.99, 128.38, 127.58, 123.80, 72.94, 71.84,
68.37, 57.46, 53.71, 46.75, 46.39, 41.65, 41.47, 39.47, 35.27,
34.73, 31.05, 30.77, 30.38, 28.17, 27.54, 26.37, 23.19, 22.46,
17.23, 12.41. 13C NMR (DMSO-d6): δ 173.03, 142.21, 136.45,
129.22, 127.75, 127.62, 124.77, 79.12, 70.95, 70.40, 66.21,
56.91, 52.51, 46.04, 45.72, 41.49, 41.32, 39.78, 39.22, 38.95,
38.67, 35.28, 34.92, 34.84, 34.35, 30.62, 30.55, 30.37, 28.47,
27.20, 26.17, 22.75, 22.58, 16.83, 12.23. HRMS (MALDI)
(m/z): calcd for C62H92N6O10Cl [M + Cl]: 1115.6564; found:
1115.6549.
Compound (14). yield 42% (162 mg), m.p. 145–149 °C.
FT-IR (KBr) νmax: 3430, 2932, 1744, 1451, 1227, 1163, 754.
1H NMR (CDCl3): δ 7,54 (s, 2H, CH-triazole ring), 7.33–7.20
(m, 4H, Ar–H), 5.50 (s, 4H, Ph–CH2-triazole ring), 5.19 (s,
4H, O–CH2–triazole ring), 4.88–4.69 (m, 2H, 3β–H), 3.80 (s,
4H, 3α–CH2–Br), 0.93 (s, 6H, CH3–19), 0.87 (d, J = 6.1 Hz,
6H, CH3–21), 0.62 (s, 6H, CH3–18). 13C NMR (CDCl3): δ
174.09, 166.74, 143.55, 135.59, 130.00, 129.00, 128.34,
127.55, 123.71, 57.38, 56.41, 55.92, 53.71, 42.70, 41.86,
41.22, 40.39, 40.06, 35.74, 35.28, 34.89, 34.55, 32.01,
31.90, 31.06, 30.81, 30.48, 29.67, 28.16, 26.95, 26.40, 26.36,
26.27, 24.14, 23.27, 20.81, 18.27, 12.0. ESI-MS (m/z): 1157.3
[C66H96N6O8 + CH3OH + K]+.
Compound (15). yield 39% (225 mg), 151–154 °C. FT-IR
1
(KBr) νmax: 3424, 2926, 1734, 1449, 1285, 1158, 754. H
NMR (CDCl3): δ 7,54 (s, 2H, CH-triazole ring), 7.33– 7.22
(m, 4H, Ar–H), 5.50 (s, 4H, Ph–CH2-triazole ring), 5.18 (s,
4H, O–CH2–triazole ring), 5.14 (s, 2H, 12β–H), 4.89–4.71
(m, 2H, 3β–H), 3.84 (s, 4H, 3α–CH2–Br), 0.92 (s, 6H, CH3–19),
0.78 (d, J = 6.1 Hz, 6H, CH3–21), 0.72 (s, 6H, CH3–18). 13C
NMR (CDCl3): δ 173.92, 166.70, 166.54, 143.42, 135.57,
129.99, 129.68, 128.99, 128.53, 128.34, 128.18, 127.93,
127.56, 123.75, 57.38, 54.29, 53.91, 53.70, 49.24, 49.15,
47.21, 45.11, 41.68, 41.19, 35.55, 34.70, 34.61, 34.24,
34.03, 33.98, 31.89, 31.77, 30.97, 30.55, 29.66, 27.31, 26.75,
26.35, 26.20, 25.99, 25.85, 25.49, 25.28, 23.39, 22.87, 17.40,
12.27. ESI-MS (m/z): 1135,3 [C66H96N6O10 + H]+, 1154,3
[C66H96N6O10 + H + Na]+.
2.3. Preparation of adducts of dimers (11–13)
Sample of compound (11) (10 mg, 0.0098 mmol) was
dissolved in acetonitrile. Then, phthalic acid (1.63 mg,
0.0098 mmol) was added in acetonitrile. The mixture was
evaporated to dryness.
Sample of compound (11) (10 mg, 0.0098 mmol) was
dissolved in acetonitrile. Then, terephthalic acid (1.63 mg,
0.0098 mmol) was added in acetonitrile. The mixture was
evaporated to dryness.
Sample of compound (11) (10 mg, 0.0098 mmol) was
dissolved in acetonitrile. Then, p-aminobenzoic acid